// SECTOR INVESTOR DOSSIER

Investors in Biopharma

6 investors with active positions in Biopharma unicorns — combined exposure across this sector $6B in paper valuation.

Note: combined paper valuation reflects overlapping investor positions — individual investors hold stakes in the same companies.